Accordingly, Ibrahim et al. had suggested that ZO-1 expression was negatively regulated through the NFκB pathway via PIK3R3, which indeed was found to be overexpressed in IBD patients. The gene discussed is TJP1; the disease is inflammatory bowel disease.